9 Pneumococcal carriage among Portuguese children after the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) in the National Immunization Plan

Catarina Isabel Brandão Candeias
Laboratory of Molecular Microbiology of Human Pathogens, Instituto de Tecnologia Química e Biológica António Xavier Universidade Nova de Lisboa (ITQB NOVA)
candeias@itqb.unl.pt
Sónia T. Almeida*, LMMHP, ITQB NOVA, Oeiras, Portugal; Alexandra S. Simões*, LMMHP, ITQB NOVA, Oeiras, Portugal; Bárbara Ferreira, LMMHP, ITQB NOVA, Oeiras, Portugal; Ana Raquel Cruz, LMMHP, ITQB NOVA, Oeiras, Portugal; Miguel Queirós, LMMHP, ITQB NOVA, Oeiras, Portugal; Tiago Touret, LMMHP, ITQB NOVA, Oeiras, Portugal; António Brito-Avô, Clinical Associate, MostMicro Unit, ITQB NOVA, Oeiras, Portugal; Hermínia de Lencastre, Laboratory of Molecular Genetics, ITQB NOVA, Oeiras, Portugal, and Laboratory of Microbiology and Infectious Diseases, The Rockefeller University, New York, USA; Raquel Sá-Leão, LMMHP, ITQB NOVA, Oeiras, Portugal
*C.C., S.A. and A.S. contributed equally to this work.

Leave a comment